Hematologic oncology is a field of medicine focused on the diagnosis, treatment and prevention of blood-related diseases, specifically cancer. The hematologic oncology program at Cancer Treatment Centers of America® (CTCA) provides advanced treatment options for individuals with leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma. A hematologic oncologist is a physician with training in the diagnosis and treatment of blood diseases and cancers. These oncologists are highly educated and trained in hematology, the study of blood, and oncology, the study of cancer.
Members of the hematologic oncology team at CTCA® understand the complexities of blood cancer. They are trained to diagnose and treat patients with conventional techniques such as radiation, chemotherapy and surgery. Members of the hematologic oncology team may also recommend supportive therapies to help patients manage the emotional and physical side effects of cancer.
Our hematologic oncologists have access to state-of-the-art diagnostic tools, such as lab or imaging tests, to stage and diagnose cancer. Once a diagnosis is reached, our hematologic oncologists meet with the patient to discuss the findings and recommend available treatment options. These plans are customized to meet the needs and goals of each individual patient. At CTCA, we strive to educate and empower patients to be part of the treatment decision-making process. The hematologic oncologist coordinates with other members of the patient’s care team to provide integrative cancer treatment. Hematologic oncologists at our five CTCA hospitals located across the United States collaborate with supportive care clinicians offering oncology rehabilitation, mind-body medicine, nutrition therapy and other techniques to help manage these challenges and support patients’ quality of life.